Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Circadian Dysregulation: later-stage trial registry
3 of 11 indexed Circadian Dysregulation trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 3 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Circadian Dysregulation: 11 US clinical trials tracked, 3 recruiting.
Circadian Dysregulation is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Berkeley, running 2 of these trials.
Enrollment posture brief
Registry condition circadian-dysregulation
OPEN 3 | RECR 27% | LATE 1 | EARLY 0 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)
Circadian Dysregulation lists 3 open slots (27% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Circadian Dysregulation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Circadian Dysregulation is recruiting below its size-band peers.
3 of 11 indexed trials (27.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Circadian Dysregulation research.
University of California, Berkeley accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Circadian Dysregulation trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 11 trials that report a genuine target (sentinel values excluded). 7 of those (63.6%) plan for fewer than 100 participants.
-
Circadian Dysregulation research is mostly interventional.
10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
University of California, Berkeley
NCT05986604
Nighttime Synchrony of Your Nutrition and Circadian Health
University of Utah
NCT07329283
Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)
Laura Beth Kalvas
NCT07384585
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
University of California, Berkeley
NCT05167695
Body Weight, Sleep, and Heart Health
Oregon Health and Science University
NCT03388788
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
Salk Institute for Biological Studies
NCT07203196
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
Takeda
NCT00492011
A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating
University of Wyoming
NCT03680989
Zolpidem CR and Hospitalized Patients With Dementia
Massachusetts General Hospital
NCT00814502
The Impact of Artificial Sunlight on Human Sleep and Circadian Rhythms
VA Palo Alto Health Care System
NCT03636360
Morning Light Treatment to Improve Glucose Metabolism
Northwestern University
NCT03188263
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Circadian Dysregulation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Circadian Dysregulation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Circadian Dysregulation page
11 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Circadian Dysregulation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, Berkeley sponsors the most Circadian Dysregulation trials on record, review their full trial history before evaluating a specific study. See University of California, Berkeley's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Circadian Dysregulation condition card totals 11 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.